KR20220044384A - 사람 태반으로부터의 세포 및 조혈 세포를 사용한 치료 - Google Patents

사람 태반으로부터의 세포 및 조혈 세포를 사용한 치료 Download PDF

Info

Publication number
KR20220044384A
KR20220044384A KR1020227010134A KR20227010134A KR20220044384A KR 20220044384 A KR20220044384 A KR 20220044384A KR 1020227010134 A KR1020227010134 A KR 1020227010134A KR 20227010134 A KR20227010134 A KR 20227010134A KR 20220044384 A KR20220044384 A KR 20220044384A
Authority
KR
South Korea
Prior art keywords
cells
ucb
subject
placental perfusate
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020227010134A
Other languages
English (en)
Korean (ko)
Inventor
조디 피. 거니
샤오구이 장
스테이시 허브
로버트 제이. 하리리
Original Assignee
안트로제네시스 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 안트로제네시스 코포레이션 filed Critical 안트로제네시스 코포레이션
Publication of KR20220044384A publication Critical patent/KR20220044384A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Transplantation (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020227010134A 2013-10-03 2014-10-02 사람 태반으로부터의 세포 및 조혈 세포를 사용한 치료 Ceased KR20220044384A (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201361886648P 2013-10-03 2013-10-03
US61/886,648 2013-10-03
US201361890057P 2013-10-11 2013-10-11
US61/890,057 2013-10-11
PCT/US2014/058774 WO2015051088A1 (en) 2013-10-03 2014-10-02 Therapy with cells from human placenta and hematopoietic cells
KR1020217013395A KR20210054046A (ko) 2013-10-03 2014-10-02 사람 태반으로부터의 세포 및 조혈 세포를 사용한 치료

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020217013395A Division KR20210054046A (ko) 2013-10-03 2014-10-02 사람 태반으로부터의 세포 및 조혈 세포를 사용한 치료

Publications (1)

Publication Number Publication Date
KR20220044384A true KR20220044384A (ko) 2022-04-07

Family

ID=52779130

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020227010134A Ceased KR20220044384A (ko) 2013-10-03 2014-10-02 사람 태반으로부터의 세포 및 조혈 세포를 사용한 치료
KR1020217013395A Ceased KR20210054046A (ko) 2013-10-03 2014-10-02 사람 태반으로부터의 세포 및 조혈 세포를 사용한 치료
KR1020167011298A Ceased KR20160102965A (ko) 2013-10-03 2014-10-02 사람 태반으로부터의 세포 및 조혈 세포를 사용한 치료

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1020217013395A Ceased KR20210054046A (ko) 2013-10-03 2014-10-02 사람 태반으로부터의 세포 및 조혈 세포를 사용한 치료
KR1020167011298A Ceased KR20160102965A (ko) 2013-10-03 2014-10-02 사람 태반으로부터의 세포 및 조혈 세포를 사용한 치료

Country Status (12)

Country Link
US (1) US10179152B2 (https=)
EP (1) EP3052109B8 (https=)
JP (4) JP2016531889A (https=)
KR (3) KR20220044384A (https=)
CN (1) CN105792834A (https=)
AU (3) AU2014329513A1 (https=)
CA (1) CA2926199C (https=)
DK (1) DK3052109T3 (https=)
MX (2) MX2016004209A (https=)
RU (2) RU2019131152A (https=)
WO (1) WO2015051088A1 (https=)
ZA (1) ZA201602151B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10456423B2 (en) 2016-06-13 2019-10-29 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US10426796B2 (en) 2016-06-13 2019-10-01 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US11285177B2 (en) 2018-01-03 2022-03-29 Globus Medical, Inc. Allografts containing viable cells and methods thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5437994A (en) * 1989-06-15 1995-08-01 Regents Of The University Of Michigan Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
IL107483A0 (en) * 1993-11-03 1994-02-27 Yeda Res & Dev Bone marrow transplantation
EP2316919B1 (en) * 2001-02-14 2015-10-07 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
WO2004071283A2 (en) * 2003-02-13 2004-08-26 Anthrogenesis Corporation Use of umbilical cord blood to treat individuals having a disease, disorder or condition
CN101389754A (zh) * 2005-12-29 2009-03-18 人类起源公司 胎盘干细胞和第二来源干细胞的联合培养
WO2007089627A2 (en) * 2006-01-27 2007-08-09 Auxocell Laboratories, Inc. Methods and compositions relating to stem cell transplantation
EP2023717B1 (en) * 2006-05-11 2016-04-13 Anthrogenesis Corporation Methods for collecting placenta cord blood stem cells
NZ599825A (en) * 2007-09-28 2014-10-31 Anthrogenesis Corp Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells

Also Published As

Publication number Publication date
RU2016116816A3 (https=) 2018-08-02
CA2926199A1 (en) 2015-04-09
ZA201602151B (en) 2022-12-21
MX2021003798A (es) 2021-05-27
US10179152B2 (en) 2019-01-15
EP3052109A1 (en) 2016-08-10
AU2020202076A1 (en) 2020-04-09
JP2016531889A (ja) 2016-10-13
NZ718571A (en) 2023-12-22
JP2021107407A (ja) 2021-07-29
AU2014329513A1 (en) 2016-04-28
EP3052109A4 (en) 2017-05-03
WO2015051088A1 (en) 2015-04-09
EP3052109B1 (en) 2021-05-12
KR20160102965A (ko) 2016-08-31
JP2023078156A (ja) 2023-06-06
EP3052109B8 (en) 2021-06-23
US20160235790A1 (en) 2016-08-18
CA2926199C (en) 2022-05-17
MX2016004209A (es) 2016-07-11
RU2019131152A3 (https=) 2022-02-24
JP2019194211A (ja) 2019-11-07
DK3052109T3 (da) 2021-08-16
KR20210054046A (ko) 2021-05-12
RU2016116816A (ru) 2017-11-13
RU2019131152A (ru) 2019-11-11
CN105792834A (zh) 2016-07-20
AU2022215207A1 (en) 2022-09-01

Similar Documents

Publication Publication Date Title
AU2014221330B2 (en) Combined organ and hematopoietic cells for transplantation tolerance of grafts
AU2022215207A1 (en) Therapy with cells from human placenta and hematopoietic cells
Barker et al. A “no-wash” albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infusion reactions
KR20190004832A (ko) 조산 합병증의 치료에 있어서의 제대혈의 용도
JP2024016037A (ja) ヒト胎盤灌流液細胞、その亜集団を含む組成物、およびそれらの使用
Dhot et al. Cord blood stem cell banking and transplantation
Sivakumaran et al. Umbilical cord blood banking and its therapeutic uses
HK1227309B (en) Therapy with cells from human placenta and hematopoietic cells
O’Donoghue Implications of fetal stem cell trafficking in pregnancy
HK1227309A1 (en) Therapy with cells from human placenta and hematopoietic cells
WO2021034996A2 (en) Treatment of cardiovascular diseases
Wacharaprechanont et al. Cord blood collection for the national cord blood bank in Thailand
Royo et al. Prenatal Diagnosis and Early Treatment of Immunodeficiencies in Man
RU2590688C2 (ru) Способ получения суспензии ядросодержащих клеток из пуповинной крови со стандартизированной концентрацией
WO2023275880A1 (en) Method of obtaining hsc population, t cell population and nk cell population and compositions thereof
Najem et al. Umbilical Cord Blood Hematopoietic Stem Cell Transplantation, an Alternative to Bone Marrow
Yasmin et al. Umbilical Cord Blood Saving-A Lifeline for a Lifetime
Roback et al. HPC Products
Solves et al. Unrelated Cord Blood Banking and Transplantation: Implications for Obstetricians

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20220325

Application number text: 1020217013395

Filing date: 20210503

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20220422

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20220623

Patent event code: PE09021S01D

E90F Notification of reason for final refusal
PE0902 Notice of grounds for rejection

Comment text: Final Notice of Reason for Refusal

Patent event date: 20230405

Patent event code: PE09021S02D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20231013

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20230405

Comment text: Final Notice of Reason for Refusal

Patent event code: PE06011S02I

Patent event date: 20220623

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I